ALFA Finder| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 69.4 | 56.8 | 38.3 |
| Other income | 1.2 | 2.9 | 0.7 |
| Total income | 70.6 | 59.7 | 38.9 |
| Profit before exceptional items & tax | 3.3 | 8.3 | 2.4 |
| Profit before tax | 3.3 | 8.3 | 2.4 |
| Net profit | 2.5 | 5.9 | 1.8 |
| Operating margin | 4.7% | 13.9% | 6.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +38.90% |
|---|---|
| Net profit, quarter on quarter | -57.60% |
| Revenue, year on year | +81.20% |
| Operating profit, year on year | +23.50% |
| Operating profit, quarter on quarter | -61.10% |
BSE results filing, NSE: MEDICO. Figures extracted from the filing.
Medico Remedies Ltd: key numbers
- Share price
- ₹19.06
- Market cap
- ₹158.2 Cr
- Revenue (annual)
- ₹206.4 Cr
- Net profit (annual)
- ₹13.12 Cr
- P/E (TTM)
- 11.6×Sector 43.8×
- Promoter holding
- 61.38%+0.00% QoQ
- FII holding
- 0.60%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medico Remedies Ltd
All →Medico Remedies Other Announcement
Medico Remedies appointed V. J. Talati & Co as cost auditor for 12 months. The appointment is an outcome of a board meeting held November 9, 2026.
- Execution
- 12 months
Medico Remedies Q2 FY27 Results: Net Profit ₹2.4 Cr, Down 7.7% YoY
Medico Remedies Ltd reported revenue from operations of ₹74 Cr (+40.7% YoY) and net profit of ₹2.4 Cr (-7.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹2.4 Cr · -7.7% YoY
Medico Remedies Board Meeting Date
Medico Remedies gave advance notice of a 9 November 2026 board meeting to consider unaudited standalone results for the quarter ended September 2026. The trading window is closed from 1 October to 12 November 2026.
Medico Remedies Other Announcement
Medico Remedies Ltd has filed its quarterly shareholding pattern statement for the period ended September 30, 2026. This is a periodic regulatory compliance filing.
Medico Remedies Price Movement Clarification
Medico Remedies confirmed to the exchanges that the recent stock price movement is driven by market conditions and no undisclosed information exists.
Medico Remedies Annual General Meeting
Medico Remedies Ltd held its 32nd Annual General Meeting on September 22, 2026, transacting ordinary and special business, including director re-appointments and remuneration revisions.